• Product NameEntecavir
• Brief DescriptionInhibitors
• Purification99.89%
• Biological ActivityEntecavir(BMS200475; SQ34676) is a guanosine analogue that inhibits reverse transcription, DNA replication and transcription in the viral replication process; oral antiHBV drug.
• Target NameHBV inhibitor
• CAS No. 142217-69-4
• Calculated MW 277.28
• Formulation C12H15N5O3
• Storage 3 years -20˚C powder;2 years -80˚C in solvent;

• Research Area:Immunology
  SMILES:C=C1[C@H](C[C@@H]([C@H]1CO)O)N2C=NC3=C2NC(=NC3=O)N
  Pathways:Microbiology&virology
  Receptor:HBV( HepG2 cell)
  Boling pt:
  Melting pt:
  Solubility:DMSO: 10 mM
  Appearance:White Powder
  Remark:For obtaining a higher solubility , please warm the tube at 37 ˚C and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20 ˚C for several month.

1. Levine S, et al. Antimicrob Agents ChemOthers, 2002, 46(8), 2525-2532.

• Flow Cytometry (FCM) General Protocol
• Immunofluorescence(IC)
• Immunohistochemistry(Polymer)
• Western Blotting